Health Products

Mitoxantrone Injection USP (2015-08-27)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
B024636AARMitoxantrone Injection USP
Recalling Firm
Hospira Healthcare Corporation
2600 Alfred Nobel Blvd, Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
2600 Alfred Nobel Blvd, Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA
SolutionDIN 02244614Mitoxantrone 2 mg/mL

Introduction

Affected Products

Mitoxantrone Injection USP

Reason

Product may not support the specification results for known impurity prior to expiry.

Depth of distribution

Hospitals (Including pharmacies)
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime